How Testing for Acquired vs. Intrinsic Mutations in HR+/HER2- Metastatic Breast Cancer Differs
Megan Kruse, MD
PeerExamining the Economic Impacts of Biosimilars in Oncology
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
PeerRecognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
PeerUnderstanding the Role of the Alternate Complement Pathway in PNH
Managing PNH: Clinical Considerations
Stories in PNH: Case Experiences from the Clinic
Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies